ARTICLE | Clinical News
Ruconest conestat alfa regulatory update
April 1, 2013 7:00 AM UTC
Pharming said EMA granted approval to allow contract manufacturing organization Sanofi Chimie to manufacture Ruconest conestat alfa to treat acute attacks of hereditary angioedema (HAE) at its Aramon...